Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.

2.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

3.

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

4.

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

5.

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot